XML 73 R52.htm IDEA: XBRL DOCUMENT v3.20.4
Revenues - Narrative (Details)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2020
USD ($)
Sep. 30, 2020
USD ($)
Jun. 30, 2020
USD ($)
Mar. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Sep. 30, 2019
USD ($)
Jun. 30, 2019
USD ($)
Mar. 31, 2019
USD ($)
Dec. 31, 2020
USD ($)
segment
customer
Dec. 31, 2019
USD ($)
customer
Dec. 31, 2018
USD ($)
customer
Revenue from Contract with Customer [Abstract]                      
Number of operating segments | segment                 1    
Revenue from External Customer [Line Items]                      
Number of major customers (as defined) accounting for more than 10% of total revenue | customer                 3 3 3
Major customers (as defined) accounting for more than 10% of gross trade receivables | customer                 3 3  
Combined trade receivables for all major customers (as defined) as a percentage of net trade receivables 74.00%       73.00%       74.00% 73.00%  
Percentage of worldwide gross revenues derived from major customers (as defined) on a combined basis                 83.00%    
Total product sales                 $ 25,424 $ 23,362 $ 23,747
Percentage of net trade receivables due from customers located outside the United States, primarily in Europe 28.00%       27.00%       28.00% 27.00%  
US [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 $ 18,496 $ 17,224 18,358
ROW [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 6,928 6,138 5,389
Product sales [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales $ 6,334 $ 6,104 $ 5,908 $ 5,894 $ 5,881 $ 5,463 $ 5,574 $ 5,286 24,240 22,204 22,533
Product sales [Member] | US [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 17,985 16,531 17,429
Product sales [Member] | ROW [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 6,255 5,673 5,104
Enbrel® (etanercept) [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 4,996 5,226 5,014
Enbrel® (etanercept) [Member] | US [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 4,855 5,050 4,807
Enbrel® (etanercept) [Member] | ROW [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 141 176 207
Prolia® (denosumab) [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 2,763 2,672 2,291
Prolia® (denosumab) [Member] | US [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 1,830 1,772 1,500
Prolia® (denosumab) [Member] | ROW [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 933 900 791
Neulasta® (pegfilgrastim) [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 2,293 3,221 4,475
Neulasta® (pegfilgrastim) [Member] | US [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 2,001 2,814 3,866
Neulasta® (pegfilgrastim) [Member] | ROW [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 292 407 609
Otezla [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 2,195 178 0
Otezla [Member] | US [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 1,790 139 0
Otezla [Member] | ROW [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 405 39 0
XGEVA® (denosumab) [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 1,899 1,935 1,786
XGEVA® (denosumab) [Member] | US [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 1,405 1,457 1,338
XGEVA® (denosumab) [Member] | ROW [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 494 478 448
Aranesp® (darbepoetin alfa) [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 1,568 1,729 1,877
Aranesp® (darbepoetin alfa) [Member] | US [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 629 758 942
Aranesp® (darbepoetin alfa) [Member] | ROW [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 939 971 935
Kyprolis [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 1,065 1,044 968
Kyprolis [Member] | US [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 710 654 583
Kyprolis [Member] | ROW [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 355 390 385
Repatha (evolocumab) [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 887 661 550
Repatha (evolocumab) [Member] | US [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 459 376 358
Repatha (evolocumab) [Member] | ROW [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 428 285 192
Other products [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 6,574 5,538 5,572
Other products [Member] | US [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 4,306 3,511 4,035
Other products [Member] | ROW [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 2,268 2,027 1,537
Other revenues [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 1,184 1,158 1,214
Other revenues [Member] | US [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 511 693 929
Other revenues [Member] | ROW [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 673 465 285
AmerisourceBergen Corporation [Member] | Product sales [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 14,743 12,301 12,091
McKesson Corporation [Member] | Product sales [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 13,779 11,795 11,434
Cardinal Health, Inc. [Member] | Product sales [Member]                      
Revenue from External Customer [Line Items]                      
Total product sales                 $ 7,332 $ 6,538 $ 7,475